首页> 外国专利> Nucleic acid constructs for presentation of CD4 and CD8 epitopes, cellular transfection and uses thereof

Nucleic acid constructs for presentation of CD4 and CD8 epitopes, cellular transfection and uses thereof

机译:用于呈递CD4和CD8表位的核酸构建体,细胞转染及其用途

摘要

The invention relates to constructs, cells and methods for modulating the immune system that optimize presentation of CD4 and CD8 epitopes to antigen-presenting cells and transfection into cells. Epitopes to either self antigens or non-self antigens can be used to optimize either a tolerance or immunogenicity to those epitopes, respectively. Certain new constructs encode one or more dominant, disease-driving epitopes (CD4) targeted for MHCII processing within the endosomes of a cell and one or more epitopes (CD8) targeted for MHCI processing within the cytosol of the cell, to produce the maximum antigen/epitope presentation in the immune system, and further include an MHCII activator sequence. Alternatively, the new constructs encode CD4 and CD8 epitopes operably linked to a secretion signal.
机译:本发明涉及用于调节免疫系统的构建体,细胞和方法,其优化了CD4和CD8表位向抗原呈递细胞的呈递以及转染入细胞。自身抗原或非自身抗原的表位可分别用于优化对那些表位的耐受性或免疫原性。某些新构建体编码一种或多种在细胞内体中靶向MHCII加工的显性疾病驱动表位(CD4)和一种或多种在细胞的胞质溶胶中靶向MHCI处理的表位(CD8)以产生最大抗原/表位在免疫系统中的表现,并进一步包括MHCII激活序列。或者,新的构建体编码可操作地连接至分泌信号的CD4和CD8表位。

著录项

  • 公开/公告号US10238741B2

    专利类型

  • 公开/公告日2019-03-26

    原文格式PDF

  • 申请/专利权人 REMI J. CREUSOT;

    申请/专利号US201715483889

  • 发明设计人 REMI J. CREUSOT;

    申请日2017-04-10

  • 分类号C12P21/02;A61K39/42;A61K35/76;A61K31;C07K14/55;C07K14/575;C07K14/735;C07K14/705;C12N9/16;C12N9/88;C07K14/47;C12N15/12;A61K39;

  • 国家 US

  • 入库时间 2022-08-21 12:12:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号